<DOC>
	<DOCNO>NCT01850758</DOCNO>
	<brief_summary>The primary objective study compare improvement subject-reported clinical outcome Regenexx SD v . Exercise Therapy treatment partial complete , non-retracted knee ACL ligament tear , baseline 3 month , continue evaluation efficacy durability 24 month . Secondary objective include evaluation MRI evidence tendon repair ; incidence post-operative complication , adverse event , re-injections , surgical intervention ; change pain score use pain medication .</brief_summary>
	<brief_title>Regenexxâ„¢ SD Versus Exercise Therapy ACL Tears</brief_title>
	<detailed_description>Prospective , randomize , control include 25 subject treat Regenexx SD 25 subject treat exercise therapy alone exercise group cross injection group 3 month . Subjects partial complete , non-retracted ACL ligament tear evidence MRI . Subjects enrol within 60 day prior Regenexx-SD injection initiation exercise therapy take part follow-up visit two year follow treatment . A preoperative visit occur time enrollment ; follow-up visit occur clinical site 6 week , 3 month , 6 month , 12 month , 24 month post injection . The primary endpoint analysis conduct subject reach 3 month endpoint . Subjects continue follow 2 year endpoint data analysis perform 1 year 2 year time point .</detailed_description>
	<criteria>Pain , swell , functional disability affect knee activity , fail conservative treatment ( e.g . NSAIDs , physician initiate physical therapy ) least 3 month unable return normal day day activity 6 week Physical examination consistent lax ACL ligament ( Anterior Drawer Test ) Abnormal Telos Arthrometer measurement Positive diagnostic MR imaging affect knee least 1/3 ACL ligament area along length high signal MRI PDFS/Fat Sat image . Full range motion affect knee ( restriction clearly due effusion ) Normal range motion nontreated knee Is independent , ambulatory , comply postoperative evaluation visit A massive ACL tear one include 2/3'rds ligament 's retract . Previous surgery affect ACL ( i.e . previous ACL replacement autograft allograft ) Prior ACL prolotherapy , PRP , corticosteroid injection injection therapy within past three month , Concomitant meniscus tear cartilage injury occur time ACL tear consider pain generator treat physician time intake study ( i.e . meniscus tear cartilage lesion associate active BML ) . Concomitant PCL , MCL , LCL tear Inflammatory autoimmune base joint disease low extremity pathology ( e.g. , rheumatoid arthritis , systemic lupus erythematosus , psoriatic arthritis , polymyalgia , polymyositis , gout pseudogout ) Quinolone Statin induce myopathy/ tendinopathy KellgrenLawrence grade 2 great knee osteoarthritis Significant knee extension lag compare opposite knee Symptomatic lumbar spine pathology ( e.g . radicular pain ) Severe neurogenic inflammation cutaneous nerve knee thigh Contraindications MRI Tested positive treat malignancy past suspected malignancy currently undergo radiation chemotherapy treatment malignancy anywhere body , whether adjacent distant propose injection site Condition represent worker 's compensation case Currently involve healthrelated litigation procedure Is pregnant Bleeding disorder Currently take anticoagulant immunosuppressive medication Allergy intolerance study medication Use chronic opioid ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ACL</keyword>
	<keyword>Anterior Cruciate Ligament</keyword>
	<keyword>ACL Tear</keyword>
	<keyword>Anterior Cruciate Ligament Tear</keyword>
	<keyword>Partial ACL Tear</keyword>
</DOC>